This track will explore the latest advancements in the diagnosis and treatment of brain tumors, focusing on novel therapeutic approaches and clinical trials. Emphasis will be placed on integrating multidisciplinary strategies to enhance patient outcomes.

This session will delve into the development of new pharmacological agents targeting neurological disorders, with a focus on mechanism of action and clinical efficacy. Researchers are encouraged to present their findings on drug discovery and therapeutic applications.

This track will cover innovative rehabilitation strategies for patients recovering from neurological injuries and disorders. Discussions will include evidence-based practices and the role of technology in enhancing rehabilitation outcomes.

This session aims to address the unique challenges faced in the diagnosis and treatment of neurological disorders in children. Topics will include developmental neurobiology and the impact of early intervention on long-term outcomes.

This track will investigate the interplay between the nervous system and endocrine functions, focusing on how neuroendocrine disorders affect neurological health. Presentations will highlight recent research findings and potential therapeutic interventions.

This session will explore the emerging field of neuroimmunology, examining the relationship between the immune system and neurological disorders. Researchers will discuss novel insights into autoimmune conditions affecting the nervous system.

This track will focus on the applications of computational models and simulations in understanding neurological processes and disorders. Contributions should highlight how computational tools can enhance diagnostic and therapeutic strategies.

This session will address contemporary approaches to the treatment and management of acute migraine, including pharmacological and non-pharmacological interventions. Participants are encouraged to share their clinical experiences and research findings.

This track will examine the role of genetic factors in the etiology and progression of neurological diseases. Presentations will focus on recent discoveries in neurogenetics and their implications for personalized medicine.

This session will provide a platform for clinicians to present unique case studies that illustrate best practices in the management of neurological disorders. Emphasis will be on sharing insights that can inform clinical decision-making.

This track will explore the latest research in molecular and cellular neuroscience, focusing on therapeutic applications for neurological conditions. Discussions will include the potential of molecular therapies in altering disease progression.